rolipram has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Narita, M | 1 |
Murata, T | 1 |
Shimizu, K | 1 |
Sugiyama, T | 1 |
Nakagawa, T | 1 |
Manganiello, VC | 1 |
Tagawa, T | 1 |
1 other study available for rolipram and Osteosarcoma
Article | Year |
---|---|
Phosphodiesterase 4 in osteoblastic osteosarcoma cells as a potential target for growth inhibition.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antineoplastic Agents; Bone Neoplasms; Cell Division; Cell Line | 2003 |